INCIDAPA M
Category: Anti-diabetic Combination
Composition: Dapagliflozin 10 mg + Metformin SR 500 mg
Overview
Combination therapy for adults with Type 2 Diabetes Mellitus requiring improved glycemic control.

Mechanism of Action
Dapagliflozin inhibits SGLT2 to increase urinary glucose excretion while Metformin improves insulin sensitivity.

Key Clinical Uses
• Complementary glucose-lowering mechanisms.
• Supports metabolic management.
• Convenient once-daily regimen where prescribed.

Dosage Form : SR Tablet
Storage
Store below 30°C in a cool, dry place. Protect from moisture and keep out of reach of children.

Disclaimer
For use by registered medical practitioners only. Prescribe according to the approved prescribing information.